tiprankstipranks
Oncopeptides AB (DE:OND)
FRANKFURT:OND
Germany Market
OND
Oncopeptides AB
RESEARCH TOOLSreports

Oncopeptides AB (OND) Ratios

6 Followers

Oncopeptides AB Ratios

DE:OND's free cash flow for Q2 2026 was kr0.97. For the 2026 fiscal year, DE:OND's free cash flow was decreased by kr and operating cash flow was kr-1.64. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.78 2.63 4.23 4.52 4.25
Quick Ratio
 3.57 2.45 4.14 4.46 4.25
Cash Ratio
 2.85 1.85 3.48 3.86 4.02
Solvency Ratio
 -1.08 -1.24 -1.45 -1.31 -3.52
Operating Cash Flow Ratio
 -3.42 -5.01 -5.07 -6.22 -4.91
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 -70.10
Net Current Asset Value
kr 11.57Mkr -76.57Mkr 27.17Mkr 21.30Mkr 273.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.61 1.03 0.58 0.53 0.02
Debt-to-Equity Ratio
 5.42 -2.37 2.61 2.22 0.03
Debt-to-Capital Ratio
 0.84 1.73 0.72 0.69 0.03
Long-Term Debt-to-Capital Ratio
 0.84 1.87 0.69 0.65 0.00
Financial Leverage Ratio
 8.91 -2.29 4.50 4.20 1.31
Debt Service Coverage Ratio
 -9.14 -15.27 -20.71 -40.15 -46.48
Interest Coverage Ratio
 -9.10 -15.63 -22.40 -43.81 -395.64
Debt to Market Cap
 0.34 0.12 0.47 0.15 <0.01
Interest Debt Per Share
 0.41 0.68 0.93 1.04 0.13
Net Debt to EBITDA
 0.11 -0.26 0.14 0.20 1.05
Profitability Margins
Gross Profit Margin
96.40%82.96%91.59%103.06%99.93%
EBIT Margin
-211.09%-321.75%-858.04%-688.99%-4031.08%
EBITDA Margin
-210.44%-308.30%-827.24%-657.64%-3825.43%
Operating Profit Margin
-211.09%-317.62%-895.78%-719.61%-4181.33%
Pretax Profit Margin
-221.92%-348.95%-898.03%-705.41%-4041.65%
Net Profit Margin
-223.55%-350.94%-899.29%-707.30%-4044.90%
Continuous Operations Profit Margin
-223.55%-350.94%-899.29%-707.30%-4044.90%
Net Income Per EBT
100.73%100.57%100.14%100.27%100.08%
EBT Per EBIT
105.13%109.86%100.25%98.03%96.66%
Return on Assets (ROA)
-95.92%-185.10%-116.55%-104.50%-87.71%
Return on Equity (ROE)
-1725.84%423.81%-524.28%-438.73%-114.83%
Return on Capital Employed (ROCE)
-120.56%-250.05%-147.01%-131.02%-116.59%
Return on Invested Capital (ROIC)
-120.56%-230.36%-141.67%-127.63%-112.10%
Return on Tangible Assets
-95.92%-185.10%-116.55%-104.50%-87.71%
Earnings Yield
-34.07%-22.87%-109.62%-35.97%-47.41%
Efficiency Ratios
Receivables Turnover
 2.43 4.33 2.84 16.05 0.48
Payables Turnover
 0.20 17.29 0.15 -0.07 <0.01
Inventory Turnover
 0.29 1.47 0.61 -0.44 0.00
Fixed Asset Turnover
 7.13 4.02 1.17 1.02 0.41
Asset Turnover
 0.43 0.53 0.13 0.15 0.02
Working Capital Turnover Ratio
 0.54 0.60 0.20 0.16 0.04
Cash Conversion Cycle
 -381.61 311.55 -1.76K 4.29K -1.72M
Days of Sales Outstanding
 150.40 84.35 128.47 22.74 754.38
Days of Inventory Outstanding
 1.26K 248.31 599.10 -820.32 0.00
Days of Payables Outstanding
 1.79K 21.11 2.49K -5.08K 1.72M
Operating Cycle
 1.41K 332.66 727.57 -797.58 754.38
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.49 -0.98 -1.57 -2.20 -5.11
Free Cash Flow Per Share
 -0.49 -0.98 -1.57 -2.20 -5.14
CapEx Per Share
 0.00 0.00 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -729.89 -2.41K -167.73
Capital Expenditure Coverage Ratio
 0.00 0.00 -729.89 -2.41K -167.73
Operating Cash Flow Coverage Ratio
 -1.39 -1.60 -1.84 -2.22 -44.07
Operating Cash Flow to Sales Ratio
 -1.98 -3.13 -8.23 -7.94 -50.33
Free Cash Flow Yield
-47.52%-20.42%-100.36%-40.38%-59.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.10 -4.37 -0.91 -2.78 -2.11
Price-to-Sales (P/S) Ratio
 4.17 15.35 8.20 19.66 85.33
Price-to-Book (P/B) Ratio
 25.08 -18.53 4.78 12.20 2.42
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.10 -4.90 -1.00 -2.48 -1.69
Price-to-Operating Cash Flow Ratio
 -3.32 -4.90 -1.00 -2.48 -1.70
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.12 0.07 0.05 0.03
Price-to-Fair Value
 25.08 -18.53 4.78 12.20 2.42
Enterprise Value Multiple
 -1.87 -5.24 -0.85 -2.79 -1.18
Enterprise Value
 374.38M 1.15B 222.82M 645.27M 377.92M
EV to EBITDA
 -1.87 -5.24 -0.85 -2.79 -1.18
EV to Sales
 3.93 16.15 7.04 18.32 45.23
EV to Free Cash Flow
 -1.99 -5.15 -0.86 -2.31 -0.89
EV to Operating Cash Flow
 -1.99 -5.15 -0.86 -2.31 -0.90
Tangible Book Value Per Share
 0.07 -0.26 0.33 0.45 3.57
Shareholders’ Equity Per Share
 0.07 -0.26 0.33 0.45 3.57
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.25 0.31 0.19 0.28 0.10
Net Income Per Share
 -0.56 -1.10 -1.71 -1.96 -4.11
Tax Burden
 1.01 1.01 1.00 1.00 1.00
Interest Burden
 1.05 1.08 1.05 1.02 1.00
Research & Development to Revenue
 0.92 1.40 3.83 3.04 26.05
SG&A to Revenue
 2.17 2.74 6.23 1.96 10.06
Stock-Based Compensation to Revenue
 0.03 0.00 0.00 0.00 2.29
Income Quality
 0.89 0.89 0.92 1.12 1.20
Currency in SEK